The funding comes alongside the company’s acquisition of conversational AI firm Gyant.
The US Food and Drug Administration has warned that some third-party labs, many based out of India and China, are producing false or duplicated data.
The funding is being used to accelerate the company’s FASTR Trial, which is examining the company’s system for the treatment of acute decompensated heart failure.
The patient monitoring device was designed as an alternative to in-clinic tests designed to track a patient’s biopotential signals from brain activity to eye movement.
The new body has launched with backing from 11 medical device certification bodies.
Give your business an edge with our leading industry insights.
The study commissioned by the The Patients Association found that patients seeking diagnostic tests are burdened with long waits and the majority would rather test at home.
The funding comes as the company works to advance three clinical trials examining early cancer assessments across a few indications.
The expansion follows market clearance of Enable’s EnFuse wearable injector system and a renovation of the company’s headquarters.
The £10m ($12.5m) funding initiative is aimed at boosting the NHS by accelerating the development of medical devices across multiple applications ranging from identifying Alzheimer’s to predicting chronic obstructive pulmonary disease.
Amid a worldwide spike in sexually transmitted infections, medtech companies are racing to stem the tide and develop diagnostics that stay one step ahead of people’s habits.